Cloning of a novel cyanobacterial serotonin N-acetyltransferase gene CySNAT3 and its integration with transcriptomic drug repurposing in pediatric obstructive sleep-disordered breathing
Abstract
Background: Melatonin has potential therapeutic value in pediatric obstructive sleep-disordered breathing (oSDB). However, plant-based melatonin extraction faces limitations including long growth cycles, low yield, and complex purification procedures. Cyanobacteria, as photosynthetic microorganisms, offer distinct advantages such as rapid growth, low cultivation cost, and well-established genetic manipulation tools, making them ideal chassis cells for producing high-value natural products. Meanwhile, the molecular mechanisms linking tonsillar pathology to oSDB severity remain poorly understood, and translational therapeutic targets are urgently needed.
Methods: A novel cyanobacterial serotonin N-acetyltransferase gene (CySNAT3) was cloned, expressed in E. coli, and purified by Ni-NTA affinity chromatography. Its enzymatic activity was assessed by HPLC-fluorescence. Separately, differential expression analysis, WGCNA, and drug repurposing were performed on tonsillar RNA-seq data (GSE274855), followed by molecular docking to validate drug-target interactions.
Results: CySNAT3 catalyzed the conversion of serotonin to N-acetylserotonin and 5-MT to melatonin, providing an enzymatic tool for microbial melatonin production. Four high-confidence candidate drugs (sulfamethoxazole, cimetidine, diethylstilbestrol, clofibrate) were identified, with molecular docking confirming favorable binding affinities to their target proteins (CYP2C19, SLC47A1, WNT7A, SCD).
Conclusion: Cimetidine…
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.